Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
Bayer AG and BlueRock Therapeutics announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on...
LexaGene to Place Beta Unit in Human Clinical Diagnostics Laboratory
LexaGene Holdings, Inc. , a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced it has an agreement...
Dynacure Receives Orphan Drug Designation from the US FDA for DYN101 an Antisense Medicine to Treat Rare Disease Centronuclear Myopathies
Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, announced that the U.S. FDA...
Stoke Therapeutics Granted FDA Orphan Drug Designation for STK-001, an Investigational New Treatment for Dravet Syndrome
Stoke Therapeutics, Inc , a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression,...
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-105
Eton Pharmaceuticals, Inc, a specialty pharmaceutical company focused on developing and commercializing innovative drug products, announced that Aucta Pharmaceuticals' New Drug Application for ET-105,...
Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 Antibody
Aevi Genomic Medicine, Inc announced that it has obtained the right to exercise an exclusive global license for MEDI2338, a Phase 2-ready fully human...
Eloxx Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial for ELX 02 in Cystinosis
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis, cystinosis, inherited retinal disorders,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...